June 20, 2025 - 23:49

June 20. In a bold move, local officials are considering tripling the transit sales tax from 0.5% to 1.5% in order to fund the construction of a railroad reminiscent of 1970s technology. This proposal aims to have the new line operational by the 2030s, but many are questioning the practicality and relevance of such an initiative. Critics argue that investing in outdated infrastructure is a misallocation of resources, labeling the project a potential boondoggle.
Proponents of the plan suggest that it will enhance connectivity and accessibility within the region. However, detractors point to the Gold Line streetcar as an example of the limitations inherent in such older technologies. They argue that the community deserves a forward-thinking transit solution that embraces modern advancements rather than clinging to dated concepts. As discussions continue, the public is urged to consider whether this investment truly serves the needs of today and tomorrow or simply perpetuates a cycle of outdated infrastructure.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...